Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.54 |
| ▸ | MMP9 | P14780 | 4/20 | 0.54 |
| ▸ | MMP3 | P08254 | 2/20 | 0.54 |
| ▸ | ELANE | P08246 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8597730 | 0.91 | MMP2 (0.48) | MMP2MMP9MMP3ELANEKMT2A | |
| SCHEMBL4412405 | 0.81 | GAA (0.50) | MMP2MMP9MMP3ELANEKMT2A | |
| SCHEMBL4043979 | 0.79 | ELANE (0.40) | MMP2MMP9MMP3ELANEKMT2A | |
| SCHEMBL29819552 | 0.78 | LMNA (0.73) | MMP2MMP9MMP3ELANEKMT2A | |
| SCHEMBL7481702 | 0.77 | MMP2 (0.64) | MMP2MMP9MMP3ELANEKMT2A | |
| SCHEMBL30494786 | 0.74 | LMNA (0.71) | MMP2MMP9MMP3KMT2ALMNA | |
| SCHEMBL267675 | 0.72 | ELANE (0.56) | ELANEKMT2AGAAMEN1ALOX12 | |
| SCHEMBL3633588 | 0.71 | KMT2A (0.37) | MMP2ELANEKMT2AGAAMEN1 | |
| SCHEMBL11119770 | 0.70 | OPRM1 (0.36) | ELANEKMT2AGAAMEN1ALOX12 | |
| SCHEMBL265915 | 0.70 | GAA (0.41) | MMP2MMP9ELANEKMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11400048-B2 | Pharmaceutical oil-in-water nano-emulsion | SYNERGIA BIO SCIENCES PRIVATE LIMITED (IN) | 2022-08-02 | — | — | US | claimed |
| EP-3160444-B1 | A PHARMACEUTICAL OIL-IN-WATER NANO-EMULSION | SYNERGIA BIO SCIENCES PRIVATE LTD (IN) | 2021-11-24 | — | — | EP | claimed |
| US-20210077396-A1 | PHARMACEUTICAL OIL-IN-WATER NANO-EMULSION | SYNERGIA BIO SCIENCES PRIVATE LIMITED (IN) | 2021-03-18 | — | — | US | claimed |
| US-10736842-B2 | Pharmaceutical oil-in-water nano-emulsion | SYNERGIA BIO SCIENCES PRIVATE LIMITED (IN) | 2020-08-11 | — | — | US | claimed |
| US-20170143627-A1 | A PHARMACEUTICAL OIL-IN-WATER NANO-EMULSION | SYNERGIA BIO SCIENCES PRIVATE LIMITED (IN) | 2017-05-25 | — | — | US | claimed |
| EP-3160444-A1 | A PHARMACEUTICAL OIL-IN-WATER NANO-EMULSION | Synergia Bio Sciences Private Limited (IN) | 2017-05-03 | — | — | EP | claimed |
| WO-2015198350-A1 | A PHARMACEUTICAL OIL-IN-WATER NANO-EMULSION | SYNERGIA BIO SCIENCES PRIVATE LIMITED (IN) | 2015-12-30 | — | — | WO | claimed |
| US-20120110957-A1 | METHOD FOR PREPARING RAPIDLY DISINTEGRATING FORMULATION FOR ORAL ADMINISTRATION | HANMI PHARM. CO., LTD. (KR) | 2012-05-10 | — | — | US | claimed |
| US-20100105783-A1 | Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same | HANMI PHARM. CO., LTD. (KR) | 2010-04-29 | — | — | US | claimed |
| EP-2170282-A2 | METHOD FOR PREPARING RAPIDLY DISINTEGRATING FORMULATION FOR ORAL ADMINISTRATION AND APPARATUS FOR PREPARING AND PACKING THE SAME | Hanmi Pharm. Co., Ltd. (KR) | 2010-04-07 | — | — | EP | claimed |
| US-20020001617-A1 | Rapidly disintegrating tablet and process for the manufacture thereof | HANMI PHARM. CO., LTD. (KR) | 2002-01-03 | — | — | US | claimed |
| WO-2001089485-A1 | RAPIDLY DISINTEGRATING TABLET AND PROCESS FOR THE MANUFACTURE THEREOF | HANMI PHARM. CO., LTD. (KR) | 2001-11-29 | — | — | WO | claimed |
| EP-0710293-A1 | LYOPHILIZED LIGAND-RECEPTOR COMPLEXES FOR ASSAYS AND SENSORS | U.S. DRUG TESTING, INC. (US) | 1996-05-08 | — | — | EP | claimed |
| WO-1995002703-A1 | LYOPHILIZED LIGAND-RECEPTOR COMPLEXES FOR ASSAYS AND SENSORS | U.S. DRUG TESTING, INC. (US) | 1995-01-26 | — | — | WO | claimed |
| US-5354654-A | Lyophilized ligand-receptor complexes for assays and sensors | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1994-10-11 | — | — | US | claimed |
| EP-0307468-A1 | PREVENTION AND TREATMENT OF THE DELETERIOUS EFFECTS OF EXPOSING SKIN TO THE SUN, AND COMPOSITIONS THEREFOR | Ross, Peter M. (US) | 1989-03-22 | — | — | EP | claimed |
| WO-1988007371-A2 | PREVENTION AND TREATMENT OF THE DELETERIOUS EFFECTS OF EXPOSING SKIN TO THE SUN, AND COMPOSITIONS THEREFOR | THE ROCKEFELLER UNIVERSITY (US) | 1988-10-06 | — | — | WO | claimed |
| US-4753801-A | DRUGS, LOW WATER SOLUBILITY | ELI LILLY AND COMPANY (US) | 1988-06-28 | — | — | US | claimed |
| US-4734276-A | L-lysine pyruvate and l- histidine pyruvate and their use in therapy of tissue and mucosa damage | INSTITUT DR. ZIEGLER (CH) | 1988-03-29 | — | — | US | claimed |
| EP-0031561-B1 | A RECTALLY ADMINISTERED SUPPOSITORY COMPRISING A DRUG AND AN ADJUVANT | MERCK & CO. INC. (US) | 1985-04-10 | — | — | EP | claimed |